Filter
95
Filtered Results: 95
Text search:
V.
Poznyak
Featured
Recommendations
6
New Publications
10
Language
Document type
No document type
61
Guidelines
14
Studies & Reports
11
Manuals
3
Training Material
3
Strategic & Response Plan
3
Countries / Regions
Global
7
Western and Central Europe
7
Ukraine
5
Eastern Europe
4
Russia
4
Tajikistan
1
Colombia
1
Thailand
1
Kazakhstan
1
Nigeria
1
Kyrgyzstan
1
Latin America and the Carribbean
1
Bolivia
1
South Africa
1
Authors & Publishers
Publication Years
Category
Non-communicable Diseases
5
NCD
3
HIV & STI
3
Sexual Violence
2
Pediatrics
2
Cardiovascular Diseases
2
Policies & Guidelines HIV & TB
2
Policies
2
Studies & Reports
2
Project Cycle Management
1
Cancer
1
Community Health
1
Other Cancer diseases
1
Non-communicable Diseases NCD
1
Sex. & Repr. Rights
1
Countries
1
Community Health
1
Mental Health
1
Other
1
General Guidelines
1
Gynaecology & Obstetrics
1
Health Systems
1
Maternal Health
1
Primary Health Care
1
Neurology & Psychology
1
Neonatal Care
1
Disease Prevention & Control
1
Global Health
1
Pharmacy & Technologies
1
TB
1
Toolboxes
Substance Use Disorders & Addiction
21
Alcohol
13
Substance Use Disorders, Others
12
Mental Disorders
5
Neurological Disorders
5
Tobacco
5
ART Drug Resistance
4
Children/Adolescents Mental Disorders
4
Alzheimer's Disease & Dementia
4
Antiretroviral Treatment ART
4
Treatment Guidelines HIV
3
mhGAP Guides
3
TB/HIV Global
3
Epidemiology
3
Reports & Studies
3
Eastern Europe and central Asia
3
Clinical Aspects, Treatment & Prevention
2
Clinical Aspects
2
General Mental Health Guidelines
2
General Studies & Reports
2
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Training Supporting Material mhGAP
2
Epilepsy
2
Sustainable Development Goals
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
General
2
Epilepsy
2
Prevention & Strategies
2
Global Overview
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
others
2
Co-Morbidities (except TB)
2
Bipolar Affective Disorders
2
HIV and coinfection
2
Community-based Mental Health Care
2
Depression
2
Mental Health GAP Action Programme
2
Africa
1
War & Conflict
1
Violence & Child Trafficking
1
Sexual and gender-based violence (SGBV)
1
Intellectual Disability
1
Posttraumatic stress disorder Adults
1
Violence & Protection
1
Children & Adolescents
1
South Africa
1
Policies & Programmes
1
Schizophrenia
1
Opoids
1
Latin America
1
Mental Health Studies & Reports
1
Stress
1
Climate & Health
1
Cannabis
1
Global Impact: Socio-economic, health services, TB & HIV
1
MHPSS – Psychosocial Support
1
Mental Health
1
Handbooks & Manuals
1
Self-care
1
Colombia
1
Other Countries
1
Women & Maternal Health
1
Non-communicable Diseases NCD
1
Studies & Reports
1
Drug resistant TB
1
Policies and guidelines
1
Policies & Strategies
1
General Aspects
1
Mental disorders, others
1
Training
1
Research & Access
1
Self-harm & Suicide
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Anxiety Disorders
1
Training & Capacity Building
1
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage.
The toolkit provides guidance for programme managers on how to i...
Mental health conditions affect one in 10 people at any one time and account for a large proportion of non-fatal disease burden. There is a high degree of comorbidity between mental health conditions such as depression and other noncommunicable diseases (NCDs), including cardiovascular disease, diab...
The global burden of disease due to mental disorders continues to rise, especially in low- and middle-income countries (LMIC). In addition to causing a large proportion of morbidity, mental disorders – especially severe mental disorders (SMD) – are linked with poorer health outcomes and increase...
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary health care settings. The practical, step-by step modul...
Psychoactive substance use affects the functioning of the brain and leads to impaired driving
Petersen et al. Int J Ment Health Syst (2016) 10:30 DOI 10.1186/s13033-016-0060-z
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
16-17 march 2015, Geneva, Switzerland
Meeting report
Objectives and scope of the document
This document was developed to provide recommended management strategies for problems and disorders that are specifically related to the occurrence of a major stressful event. The recommended strategies will form the basis of a new module to be added to the WHO ...
Substance use disorders
Chapter G.3
BMC Medicine201210:107
https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012
Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012
In 2011, the World Health Organization’s (WHO) mental health Gap Action Programme (mhGAP) r...
The report “Dementia: a public health priority” has been jointly developed by WHO and Alzheimer's Disease International. The purpose of this report is to raise awareness of dementia as a public health priority, to articulate a public health approach and to advocate for action at international a...
PLoS Med 10(8): e1001501. https://doi.org/10.1371/journal.pmed.1001501
Las personas infectadas por el virus de la inmunodeficiencia humana (VIH) tienen
29 veces más probabilidades de enfermar de tuberculosis (TB) que las personas
sin VIH que viven en el mismo país. La TB es una de las principales causas de muerte entre las personas infectadas por el VIH: provoca ...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Módulo 4
Líderes
Julio del 2017
Módulo 4: Líderes. Este módulo tiene por objeto informar y actualizar a los líderes y a los encargados de tomar decisiones sobre la PrEP. Proporciona información sobre los beneficios y las limitaciones de la PrEP para que puedan considerar cómo pueden a...
